Guess we will know soon enough how this will play out and it won’t be because of you or me.If it keeps moving up like it did this week, along with some news in the next few weeks, FSD will prove to be a big part of anyone’s portfolio who owns it IMO. Owned this for a few years now and am liking the possible revenue streams after watching the development up to this point. The directors and experts that have been put together for creating formulations for MS and depression among others, are well known in their fields, just like Harrington and David are in their expertise in bringing ideas to market.
News 
Market Data 
Discover 
